Our Leadership

Experts shaping the future of biotherapies

With decades of experience spanning biotechnology, entrepreneurship, and company building, our leadership team not only steers scientific strategy but also builds the capabilities, teams, and execution discipline required to convert early discoveries into high-value biotherapies across our verticals.

Executive Directors

Dr. Jean-Marc Le Doussal, MBA

Founder & Chief Executive Officer

Serial entrepreneur and immunologist

Leads the Regenerative & Aesthetics and Cell & Gene Therapy verticals

Dr. David Béchard

Chief Executive Officer France

Serial entrepreneur and immunologist

Leads the Immunotherapy and Vectorized verticals

Independent Directors

Hervé Cathelin

Chairman of the Board

Ex-Vice President, Nestlé Switzerland

Dr. Charles Woler

Board Member

Ex-Chief Executive Officer, Roche France

Scientific Co-Founders

Prof. Shukry Habib

Regenerative & Aesthetics Co-Founder

Head Regenerative Medicine at University of Lausanne

Prof. Denis Migliorini, MD

Cell & Gene Therapy Co-Founder

Head Neuro-Oncology at Geneva University Hospitals

Investment Management

Richard Groenendijk

Chief Finance Officer

Dr. Jérôme Jaquier

General Counsel

Florian Le Thoer

Chief Corporate Development Officer

Albert Wagner

Chief Accounting Officer

Advancing breakthrough science together

By working together, we accelerate the translation of breakthrough ideas into biotherapies that deliver meaningful impact for patients and society.